FDA advisers back Celebrex for children despite risks

By Diedtra Henderson

Globe Staff / November 30, 2006

E-mail|
Reprints|

Text size – +

Children as young as 2 who suffer from arthritis can be treated with Celebrex , but to ensure the painkiller doesn't put them at later risk for heart attacks, their health should be tracked for decades, a Food and Drug Administration advisory panel said yesterday. (Full article: 503 words)